Methods for the production of sildenafil base and citrate salt

A technology for sildenafil and sildenafil citrate, which is applied in the field of preparing sildenafil base and its citrate, can solve problems such as difficulty in removing by-products, complicated purification, and economic limitations

Inactive Publication Date: 2007-03-07
TEVA PHARMA IND LTD
View PDF6 Cites 21 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this method uses an excess of cyclic amine, which may be economically restrictive depending on the cyclic amine used
Also, because the proto

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods for the production of sildenafil base and citrate salt

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] Embodiment 1: unconventional preparation of sildena

[0052] In a three-necked flask, benzenesulfonyl chloride-3-(4,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d )pyrimidin-5-yl)-4-ethoxyphenyl) (5g, 12.2mmol) was mixed with acetone (100ml) followed by the addition of 47% aqueous NaOH (0.487g, 10mmol). N-methylpiperazine (1.34 g, 11 mmol) was added dropwise. The reaction mixture was stirred for 45 min, then cooled to 0 °C and filtered. The precipitate was washed twice with water, and dried at 50° C. and a vacuum of 10 mmHg to obtain sildenafil with a yield of 88.8%.

Embodiment 2-13

[0054] Table 1. The yields of sildenafil synthesized using various solvents

Embodiment 14

[0055] Embodiment 14: the synthesis of sildenafil citrate

[0056] In a three-necked flask, sildenafil (5 g, 10 mmol) was dissolved in acetone (40 ml) at 50°C. In a separate vessel, citric acid (2 g, 10 mmol) was dissolved in acetone (15 ml). Both solutions were filtered. When the citric acid solution was added dropwise to the sildenafil solution, a white precipitate appeared immediately. Thereafter the reaction mixture was heated, maintained at the reflux temperature of the solvent for 1 hour, then cooled at room temperature for 3 hours. The precipitate was collected by filtration and dried at 50° C. and a vacuum of 10 mmHg to obtain sildenafil citrate with a yield of 95.5%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Provided are processes for the preparation of sildenafil base and the citrate salt sildenafil. Also provided are sildenafil citrate water adduct and a method of preparing pharmaceutical compositions comprising combining the sildenafil citrate and/or sildenafil citrate water adduct with at least one pharmaceutically-acceptable excipient.

Description

[0001] Cross References to Related Applications [0002] This application claims U.S. Patent Provisional Application 60 / 534,527, filed January 5, 2004, U.S. Patent Provisional Application 60 / 547,232, filed February 23, 2004, and U.S. Patent Provisional Application 60 / 549,268, filed March 1, 2004 interests, the contents of which are incorporated herein by reference in their entirety. field of invention [0003] The invention includes methods for preparing sildenafil and sildenafil citrate. The present invention also includes sildenafil citrate water adduct, and a method for preparing a pharmaceutical composition, comprising mixing sildenafil citrate and / or sildenafil citrate water adduct with at least one medicinal Mix with excipients. Background of the invention [0004] Sildenafil citrate is a cyclic guanosine monophosphate (cGMP) specific phosphodiesterase type 5 (PDE5) selective inhibitor commercially developed by ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/519A61P15/10C07D487/04
Inventor V·布劳德J·阿伦希姆S·夏巴特
Owner TEVA PHARMA IND LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap